APC targeting
Tolerogenics PhagoAttract technology
Tolerogenics PhagoAttract technology
“Find-me” signals arereleased from apoptotic cells to attract phagocytes including antigen-presenting cells (APCs) to the site of apoptotic cell death.
Several “find-me” signals have been identified such as fractalkine (chemokine CXC3CL1), lysophosphatidylcholine (LPC), sphingosine-1-phosphate (S1P) and the nucleotides ATP and UTP. These “find-me” signalsare regognized by corresponding receptors on the surface of phagocytes.
Using a transwell migration assay, ATP and UTP have been demonstrated to effect maximal migration of phagocytes at a concentration of about 100 nM (Elliott et al. 2009, Nature 461:282-286). Both nucleotides act as non-redundent “find-me” signals.
In contrast, at concentrations of more than 1 µM ATP exerts pro-inflammatory effects since concentrations in this range are generated by necrotic cells (Kono and Rock 2008, Nature Rev. Immunol. 8:279-289).
Phagocytes are extremely efficient in sensing and detecting apoptotic cells due to the sustained release of “find-me” molecules which generate a chemotactic gradient (for a review, see Ravichandran 2011, Immunity 35:445-455).
The hydrogel technology of Tolerogenics allows a sustained release of embedded nucleotides over a period of at least 2 days (Tolerogenics PhagoAttract technology). After a diffusion-based initial burst during the first hours, the sustained release of embedded nucleotides generates a chemotactic gradient that mimics the release of nucleotides from apoptotic cells. As a result, APCs are attracted to the hydrogel-embedded components including allergens or autoantigens and tolerance-promoting adjuvants are most efficiently phagocytosed by the attracted APCs.
More Information?
You would like to get more information about Tolerogenics key technologies? Please click here for the technology overview or here to contact us.